What Is BeOne Medicines Ltd. (ONC) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, BeOne Medicines Ltd.'s intrinsic value is estimated at $129.56. Trading at its current price of $303.96, the valuation engine raises significant caution: 12 of 13 models flag downside risk, projecting an average implied return of -57.4%. Model dispersion is worth noting: First Chicago targets $298.93 (-1.7%), versus Dynamic NAV at $55.45 (-81.8%). This +80.1% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About ONC?
13 of 13 models are currently active for ONC. All 13 active models suggest the stock trades above fair value. The Bayesian DCF estimates ONC's intrinsic value at $56.70, implying -81.3% downside from the current price. See which stocks rank higher →
How Does ONC Rank in Pharmaceutical Preparations?
Among 440 Pharmaceutical Preparations stocks, ONC ranks #24 by Quality of Company score. CirclFi's QOC score of 8.5/10 evaluates 32 fundamental signals. A score of 8.5 places ONC in the top tier.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to biopharma enterprise businesses. For BeOne Medicines Ltd., metrics like FDA approval probability provide important context that general-purpose valuation models may underweight.
Is ONC a Value Trap?
CirclFi's Value Trap algorithm assigns ONC a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for BeOne Medicines Ltd.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, BeOne Medicines Ltd. earns a quality score of 8.5/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +80.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ONC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ONC's 13 active models, average confidence is 38%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad